Anti-c-Met/anti-Ang2 bispecific antibody
US11155627B2 · kind B2 · utility
0Cited by
5References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 24, 2017 |
| Grant date | Oct 26, 2021 |
| Priority date | — |
| Expiry date | Dec 26, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An anti-c-Met/anti-Ang2 bispecific antibody, a composition including the anti-c-Met/anti-Ang2 bispecific antibody, and a method of preventing and/or treating a cancer in a subject including administering the anti-c-Met/anti-Ang2 bispecific antibody to the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.